Prevention of chronic GvHD after HLA-identical sibling peripheral hematopietic stem cell transplantation with or without anti-lymphocyte globulin (ATG). Results from a prospective, multicenter randomized phase III trial (ATGfamilystudy)

This article has no abstract
Epistemonikos ID: 3b035f6b9b7d3df6cf62fb8ac5b391985de87b18
First added on: Feb 06, 2025